Therapeutic Metabolomics
Monday Track 2 from 10:30 AM - 12:30 PM
Chair: Gary Siuzdak

Track 2

Mass spectrometry-based metabolomics is used to screen and identify metabolites altered in disease. These alterations are then used as a primary indicator of the enzyme(s) responsible, and the enzymes subsequently targeted with inhibitors for therapeutic benefits.